Bg Medicine Stock Current Ratio
| BGMDDelisted Stock | USD 0.0002 0.00 0.00% |
BG Medicine fundamentals help investors to digest information that contributes to BG Medicine's financial success or failures. It also enables traders to predict the movement of BGMD Pink Sheet. The fundamental analysis module provides a way to measure BG Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BG Medicine pink sheet.
BGMD |
BG Medicine Company Current Ratio Analysis
BG Medicine's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current BG Medicine Current Ratio | 1.65 X |
Most of BG Medicine's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BG Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, BG Medicine has a Current Ratio of 1.65 times. This is 43.3% lower than that of the Life Sciences Tools & Services sector and 52.86% lower than that of the Health Care industry. The current ratio for all United States stocks is 23.61% higher than that of the company.
BGMD Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BG Medicine's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BG Medicine could also be used in its relative valuation, which is a method of valuing BG Medicine by comparing valuation metrics of similar companies.BG Medicine is currently under evaluation in current ratio category among related companies.
BGMD Fundamentals
| Return On Equity | -9.03 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.86) % | ||||
| Current Valuation | 545.97 K | ||||
| Shares Outstanding | 11.37 M | ||||
| Number Of Shares Shorted | 630.05 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 1.57 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (4.39 M) | ||||
| Net Income | (5.3 M) | ||||
| Cash And Equivalents | 1.52 M | ||||
| Cash Per Share | 0.14 X | ||||
| Debt To Equity | 5.31 % | ||||
| Current Ratio | 1.65 X | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (3.67 M) | ||||
| Short Ratio | 2.66 X | ||||
| Earnings Per Share | (0.72) X | ||||
| Target Price | 1.4 | ||||
| Beta | 83.44 | ||||
| Market Capitalization | 545.97 K | ||||
| Total Asset | 2.13 M | ||||
| Retained Earnings | (161.49 M) | ||||
| Working Capital | 771 K | ||||
| Current Asset | 1.95 M | ||||
| Current Liabilities | 1.18 M | ||||
| Net Asset | 2.13 M |
About BG Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BG Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BG Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BG Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with BG Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BG Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BG Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against BGMD Pink Sheet
| 0.58 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | DOMH | Dominari Holdings | PairCorr |
| 0.47 | YS | YS Biopharma | PairCorr |
The ability to find closely correlated positions to BG Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BG Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BG Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BG Medicine to buy it.
The correlation of BG Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BG Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BG Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BG Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in BGMD Pink Sheet
If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |